Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (8)
  • Autophagy
    (3)
  • COX
    (2)
  • Endogenous Metabolite
    (2)
  • Fatty Acid Synthase
    (2)
  • Influenza Virus
    (2)
  • STAT
    (2)
  • Antifungal
    (1)
  • Aurora Kinase
    (1)
  • Others
    (18)
Filter
Search Result
Results for "

c-75

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    32
    TargetMol | All_Pathways
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Dye Reagents
    4
    TargetMol | All_Dye_Reagents
  • Natural Products
    4
    TargetMol | Natural_Products
  • Recombinant Protein
    39
    TargetMol | Recombinant_Protein
  • Antibody Products
    28
    TargetMol | Antibody_Products
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
trans-C75
(±)-C75
T10656191282-48-1
trans-C75 ((±)-C75) is an enantiomer of C75, which is an inhibitor of fatty-acid synthase (FASN).
  • $44
In Stock
Size
QTY
C75
C-75
T10657218137-86-1
C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: 35 μM).C75 increases CPT1 activity and reduces DIO.
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
Cis-C75
T10657L191282-49-2
Cis-C75 is a five-membered oxygen-containing heterocyclic derivative containing a carboxylic acid group, suitable for biochemical experiments and drug synthesis research.
  • $195
In Stock
Size
QTY
SC-75416
SC75416, SC 75416
T28703215122-74-0
SC-75416 is a selective COX-2 inhibitor for the study of pain.
  • $293 TargetMol
In Stock
Size
QTY
SP600125
Pyrazolanthrone, Nsc75890, JNK Inhibitor II, 1PMV
T3109129-56-6
SP600125 (JNK Inhibitor II) is a JNK inhibitor that inhibits JNK1, JNK2, and JNK3 (IC50=40/40/90 nM) with oral potency, reversibility, and ATP-competitive properties. SP600125 inhibits autophagy and induces apoptosis.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Sulfinpyrazone
NSC 75925, G-28315, (+/-)-Sulfinpyrazone
T043557-96-5
Sulfinpyrazone (NSC-75925) is a uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
  • $29
In Stock
Size
QTY
Trifluridine
Viroptic, Trifluridina, Trifluorothymidine, NSC 75520, NSC 529182, 5-Trifluorothymidine
T142870-00-8
Trifluridine (NSC-75520) is a fluorinated thymidine analog with potential antineoplastic activity. Trifluridine is incorporated into DNA and inhibits thymidylate synthase, resulting in inhibition of DNA synthesis, inhibition of protein synthesis, and apoptosis. This agent also exhibits antiviral activity.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
LDC7559
T118282407782-01-6
LDC7559 inhibits gasdermin D (GSDMD) by blocking neutrophil extracellular trap (NET) at late stage.
  • $64
In Stock
Size
QTY
Odapipam
NNC 756
T12288131796-63-9
Odapipam is a selective and high affinity antagonist of benzazepine dopamine D1 receptor (Kd of 0.18 nM).
  • $1,220
6-8 weeks
Size
QTY
GANT 58
NSC 75503
T1537064048-12-0
GANT 58 (NSC-75503) is a potent antagonist of Gli. Which inhibits GLI1-induced transcription (IC50: 5 μM).
  • $40
In Stock
Size
QTY
Pentaerythritol diacrolein acetal
NSC-7585, NSC7585, NSC 7585
T2021078-19-3
Pentaerythritol diacrolein acetal is an agent of biochemical.
  • Inquiry Price
3-6 months
Size
QTY
NSC756093
NSC-756093, NSC 756093
T245571629908-92-4
NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.
  • $39
In Stock
Size
QTY
C.I. 62100
NSC-7579, NSC7579, NSC 7579
T30658128-83-6
C.I. 62100 is a biochemical.
  • $1,520
2-4 weeks
Size
QTY
Purine
7H-Imidazo(4,5-d)pyrimidine
T4746120-73-0
Purine (7H-Imidazo(4,5-d)pyrimidine) is a heterocyclic aromatic organic compound, consisting of a pyrimidine ring fused to an imidazole ring. Two of the bases in nucleic acids, adenine and guanine, are purines. Purines from food (or from tissue turnover) are metabolised by several enzymes, including xanthine oxidase, into uric acid. High levels of uric acid can predispose to gout when the acid crystalises in joints; this phenomenon only happens in humans and some animal species (e.g. dogs) that lack an intrinsic uricase enzyme that can further degrade uric acid.
  • $29
In Stock
Size
QTY
SC75741
T6661913822-46-5
SC75741 is a potent P65 inhibitor with IC50 of 200 nM
  • $36
In Stock
Size
QTY
TargetMol | Citations Cited
Timelotem
KC-7507 free base
T8815696306-34-2
Timelotem represents a class of 1,2-fused 1,4-benzodiazepine drugs. Timelotem exhibits significant antipsychotic properties. It produces sedative, anxiolytic, and anticonvulsant effects by enhancing the action of the neurotransmitter γ-aminobutyric acid (GABA). Timelotem may be used in research on schizophrenia and other psychiatric disorders.
  • $1,670
8-10 weeks
Size
QTY
Isoliquiritigenin
Isoliquiritigen, ISL, GU17
T0725961-29-5
Isoliquiritigenin (ISL) is a flavonoid natural product that inhibits influenza virus replication (EC50=24.7 μM) and aldose reductase activity (IC50=320 nM). Isoliquiritigenin has antitumor activity.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
(1,3-Dimethyl-1H-thieno[2,3-c]pyrazol-5-yl)methanol
Fr12447423769-75-9
(1,3-Dimethyl-1H-thieno[2,3-c]pyrazol-5-yl)methanol ,with CAS No. 423769-75-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. (1,3-Dimethyl-1H-thieno[2,3-c]pyrazol-5-yl)methanol provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CHMFL-ABL/KIT-155
CHMFL-ABL-KIT-155
T108012081093-21-0
CHMFL-ABL/KIT-155 is a highly potent and orally active type II ABL/c-KIT dual kinase inhibitor (IC50s: 46 nM/75 nM). It arrests cell cycle progression and induces apoptosis.
  • $1,670
6-8 weeks
Size
QTY
PPO-IN-17
T205070
PPO-IN-17 (Compound 6R) functions as an inhibitor of protoporphyrinogen IX oxidase (PPO), effectively inhibiting tobacco PPO (NtPPO) with a Ki of 30.34 nM. This compound demonstrates herbicidal activity, achieving an inhibition rate greater than 95% against E. crus-galli, D. sanguinalis, M. sativa, and C. canadensis at a concentration of 37.5 g/hm2. Additionally, PPO-IN-17 shows no toxicity to rice at 75 g/hm2 and to bees at 6400 mg/kg.
  • Inquiry Price
Inquiry
Size
QTY
STAT-3/c-Src-IN-1
T212271
STAT-3/c-Src-IN-1 (Compound 12d) is a dual inhibitor of STAT-3 (IC50=0.844 μM) and c-Src (IC50=0.268 μM). It effectively disrupts tumor cell proliferation, migration, and angiogenesis pathways. This compound exhibits potent antiproliferative activity against melanoma (SK-MEL-2) and central nervous system cancer (SNB-75) cell lines, with GI50 values of -5.75 μM and -5.63 μM, respectively. It induces apoptosis through cell cycle arrest at the G0/G1 and G2/M phases. STAT-3/c-Src-IN-1 shows promise for research in melanoma and glioblastoma.
  • Inquiry Price
Inquiry
Size
QTY
Ajoene
T3562492285-01-3
Ajoene is a disulfide that has been found inA. sativumand has diverse biological activities, including antibacterial, anticancer, antiplatelet, and antioxidant properties.1,2,3,4It is active against Gram-positive (MICs = 5-160 µg/ml) and Gram-negative bacteria (MICs = 136-200 µg/ml), as well as yeasts (MICs = 10-20 µg/ml).1Ajoene is cytotoxic to mouse melanoma cells (IC50= 18 µM), as well as human colon, lung, mammary, and pancreatic cancer cells (IC50s = 7-41 µM).2It reduces tumor growth in a B16/BL6 mouse model of melanoma when administered at a dose of 25 mg/kg every other day and decreases the number of lung metastases when administered prior to tumor cell inoculation at doses ranging from 1-25 mg/kg. It inhibits ADP- or collagen-induced platelet aggregation in isolated baboon platelets when used at concentrations ranging from 75 to 150 µg/ml and in platelet-rich plasma isolated from baboons when administered at a dose of 25 mg/kg.3Ajoene (25 mg/kg) prevents thrombus formation on damaged arterial walls in heparinized pigs in anin situmodel of thrombogenesis.5It also reduces high-fat diet-induced hepatic steatosis, histopathological markers of liver damage, thiobarbituric acid reactive substances (TBARS) formation, and protein oxidation in a mouse model of non-alcoholic fatty liver disease (NAFLD).4 1.Naganawa, R., Iwata, N., Ishikawa, K., et al.Inhibition of microbial growth by ajoene, a sulfur-containing compound derived from garlicAppl. Environ. Microbiol.62(11)4238-4242(1996) 2.Taylor, P., Noriega, R., Farah, C., et al.Ajoene inhibits both primary tumor growth and metastasis of B16/BL6 melanoma cells in C57BL/6 miceCancer Lett.239(2)298-304(2006) 3.Teranishi, K., Apitz-Castro, R., Robson, S.C., et al.Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoeneXenotransplantation10(4)374-379(2003) 4.Han, C.Y., Ki, S.H., Kim, Y.W., et al.Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activationAntioxid. Redox Signal.14(2)187-202(2011) 5.Apitz-Castro, R., Badimon, J.J., and Badimon, L.A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental modelThromb. Res.75(3)243-249(1994)
  • $2,558
Inquiry
Size
QTY
AAA
T35855
AAA is an antagonist of G protein-coupled receptor 75 (GPR75).1It increases basal GPR75 protein levels and inhibits 20-HETE-induced reductions in GPR75 protein levels in PC3 cells. AAA (5 and 10 μM) also reduces 20-HETE-induced phosphorylation of EGFR, NF-κB, and Akt in, and cell migration of, PC3 cells.In vivo, AAA (10 mg/kg per day) reduces systolic blood pressure, albuminuria, renal angiotensin II levels, and cardiac hypertrophy in a Cyp1a1-Ren-2 transgenic rat model of malignant hypertension when administered prior to induction or after establishment of hypertension.2 1.Cárdenas, S., Colombero, C., Panelo, L., et al.GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cellsBiochim. Biophys. Acta Mol. Cell Biol. Lipids1865(2)158573(2020) 2.Sedláková, L., Kikerlová, S., Husková, Z., et al.20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic ratsBiosci. Rep.38(5)BSR20171496(2018)
  • $1,299
Inquiry
Size
QTY
Arecaidine propargyl ester (hydrobromide)
T36241116511-28-5
Arecaidine propargyl ester is an agonist of M2muscarinic acetylcholine receptors (mAChRs).1It selectively binds to M2over M1, M3, M4, and M5mAChRs in CHO cells expressing the human receptors (Kis = 0.0871, 1.23, 0.851, 0.977, and 0.933 μM, respectively). Arecaidine propargyl ester induces contractions in isolated guinea pig atrium (pD2= 8.67). It induces apoptosis and the production of reactive oxygen species (ROS) in U87 and U251 glioblastoma cells when used at a concentration of 100 μM.2Arecaidine propargyl ester decreases mean arterial blood pressure in normotensive cats (ED25= 1.9 nmol/kg).3It is toxic to house flies (Musca) when administered at a dose of 75 μg/fly.4 1.Scapecchi, S., Matucci, R., Bellucci, C., et al.Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonistJ. Med. Chem.49(6)1925-1931(2006) 2.Di Bari, M., Tombolillo, B., Conte, C., et al.Cytotoxic and genotoxic effects mediated by M2 muscarinic receptor activation in human glioblastoma cellsNeurochem. Int.90261-270(2015) 3.Porsius, A.J., and Van Zwieten, P.A.Central action of some cholinergic drugs (arecaidine esters) and nicotine on blood pressure and heart rate of catsProg. Brain Res.47131-135(1977) 4.Honda, H., Tomizawa, M., and Casida, J.E.Insect muscarinic acetylcholine receptor: Pharmacological and toxicological profiles of antagonists and agonistsJ. Agric. Food Chem.55(6)2276-2281(2007)
  • $223
35 days
Size
QTY